1. Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, and
2. Faculty of Biology, University of Freiburg, Freiburg, Germany;
3. Department of Human Genetics, Hannover Medical School, Hannover, Germany;
4. Immune Deficiency–Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD;
5. Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD;
6. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX;
7. St. Anna Childreńs Hospital and Cancer Research Institute, Pediatric Clinic, Medical University of Vienna, Vienna, Austria;
8. Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands;
9. Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic;
10. Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark;
11. Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, MA;
12. Department of Pathology, Boston Children's Hospital, Boston, MA;
13. Department of Oncology and
14. Department of Hematology, St Jude Children’s Research Hospital, Memphis, TN;
15. Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;
16. Department of Medicine, Hematology and Bone Marrow Transplantation Unit, University of Perugia, Perugia, Italy;
17. Department of Medicine, Division of Hematology, University of Washington, Seattle, WA;
18. Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX;
19. Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom;
20. Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel;
21. Sackler Faculty of Medicine, Tel Aviv University, Israel;
22. Department of Pediatrics and
23. Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan;
24. Department of Computational Biology, St Jude Children's Research Hospital, Memphis, TN;
25. Hematology Department, Oncology Institute Francisco Gentil, Lisbon, Portugal;
26. Laboratory of Molecular Diagnostics, Central Hospital of Southern Pest, Budapest, Hungary;
27. National Children's Cancer Service, Children's Health Ireland at Crumlin, Dublin, Ireland;
28. Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;
29. Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway;
30. Department of Genetics, The National Institute of Oncology, Bratislava, Slovakia;
31. Department of Hematology, Genetics Unit, Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Hospital Universitario y Politécnico La Fe, Valencia, Spain;
32. Department of Clinical Genetics, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland;
33. New Children's Hospital, Pediatric Research Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland;
34. Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, Stockholm, Sweden;
35. Department of Biodiagnostic Sciences and Technologies, The Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES), National Centre for Research 'Demokritos', Athens, Greece;
36. Labdia Labordiagnostik GmbH, Clinical Genetics, Vienna, Austria;
37. Medical Genetics, Department of Medicine and Surgery, University of Insubria, Varese, Italy;
38. Laboratory for Oncology, University Children's Hospital Zürich, Zürich, Switzerland;
39. Department of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden;
40. Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium;
41. Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine of Charles University, Prague, Czech Republic; and
42. German Cancer Consortium (DKTK), Freiburg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany